EUVIMEDEUVIMED entdecken
Crossref

RGD-decorated nanoliposomes for combined delivery of arsenic trioxide and curcumin to prostate cancer cells

Fatemeh Khosravani, Fatemeh Amiri, Rouzbeh Mahmoudi, Dina Morshedi, Farzad Kobarfard, Mohsen Alipour, Ebrahim Hosseini, Hassan Bardania

Naunyn-Schmiedeberg's Archives of Pharmacology · 2024

DOI: 10.1007/s00210-023-02752-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2024. Verfasst von Fatemeh Khosravani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Yasuj University of Medical Sciences, Yasuj, Iran. Hauptthemen laut MEDLINE: Curcumin, Antineoplastic Agents, Prostatic Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanotechnology and drug co-delivery offer a novel avenue in drug delivery research liposome-based co-delivery of anticancer drugs targeting the apoptosis pathway as a promising new approach to treat cancer. In this study, a co-delivery system of liposomes (arsenic trioxide/curcumin) modified with RGD peptide was designed to aim for enhancing the treatment of prostate cancer cells (PC3 cell line). Liposomal co-loaded curcumin and arsenic trioxide modified by RGD peptide (NLPs-RGD-Cur-ATO) were prepared by thin-layer lipid hydration techniques for the treatment of prostate cancer. The stability of the NLPs-RGD-Cur-ATO was evaluated by particle size analysis through dynamic light scattering (DLS) analysis and transmission electron microscopy (TEM). The percentage of cytotoxicity and apoptotic effect in PC3 cells treated with NLPs-RGD-Cur-ATO were detected by MTT and Annexin V-FITC (fluorescein isothiocyanate)/PI affinity assay, respectively. The particle size of NLPs-RGD-Cur-ATO was approximately 100 nm, with an encapsulation efficiency of about 99.52% and 70.61%, for ATO and Cur, respectively. Besides, NLPs-RGD-Cur-ATO displayed an enhanced anti-proliferative effect, increased the percentage of apoptotic cells 98 ± 1.85% (p < 0.0001), and significantly reduced EGFR gene expression level (p < 0.001) in the cell line tested. These results indicated that our NLPs-RGD-Cur-ATO co-delivery system was a promising strategy for prostate cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminAntineoplastic AgentsProstatic NeoplasmsMaleHumansArsenic TrioxideDrug Delivery SystemsLiposomesOligopeptidesCell Line, TumorApoptosis

Stichwörter der Autor:innen

Arsenic trioxideCurcuminEGFRNanoliposomesProstate cancerRGD peptide

Substanzen

Arsenic TrioxideCurcuminarginyl-glycyl-aspartic acidAntineoplastic AgentsLiposomesOligopeptides

Autor:innen und Institutionen

  • Student Research Committee, Yasuj University of Medical Sciences, Yasuj, Iran.
  • Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.
  • Bioprocess Engineering Research Group, Department of Industrial and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran.
  • Department of Medical Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Shams Alley, Vali-E-Asr Ave, Tehran, Iran.
  • Phytochemistry Research Center, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Shams Alley, Vali-E-Asr Ave, Tehran, Iran.
  • Department of Advanced Medical Sciences & Technologies, School of Medicine, Jahrom University of Medical Sciences, Jahrom, Iran.

Zitieren

APA

Khosravani, F., Amiri, F., Mahmoudi, R., Morshedi, D., Kobarfard, F., Alipour, M., Hosseini, E., & Bardania, H. (2024). RGD-decorated nanoliposomes for combined delivery of arsenic trioxide and curcumin to prostate cancer cells. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-023-02752-7

Vancouver

Khosravani F, Amiri F, Mahmoudi R, Morshedi D, Kobarfard F, Alipour M, et al. RGD-decorated nanoliposomes for combined delivery of arsenic trioxide and curcumin to prostate cancer cells. Naunyn-Schmiedeberg's Archives of Pharmacology. 2024. doi:10.1007/s00210-023-02752-7

BibTeX
@article{Khosravani2024,
  author = {Khosravani, Fatemeh and Amiri, Fatemeh and Mahmoudi, Rouzbeh and Morshedi, Dina and Kobarfard, Farzad and Alipour, Mohsen and Hosseini, Ebrahim and Bardania, Hassan},
  title = {RGD-decorated nanoliposomes for combined delivery of arsenic trioxide and curcumin to prostate cancer cells},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2024},
  doi = {10.1007/s00210-023-02752-7}
}
Kostenlos starten →